Quick Comparison
| Bacopa Monnieri | Tianeptine | |
|---|---|---|
| Half-Life | 2-6 hours (bacosides) | 2.5-3 hours (tianeptine), 7-8 hours (active metabolite MC5) |
| Typical Dosage | Standard: 300-600 mg daily of extract standardized to 50% bacosides (e.g., Bacognize or Synapsa). Take with fat for absorption. Allow 8-12 weeks for full effects. Evening dosing preferred due to mild sedation. | Prescription dose: 12.5 mg three times daily (Stablon). Extended-release: 25 mg once daily (Tianeurax). Do not exceed prescribed doses — abuse potential at higher doses due to opioid activity. |
| Administration | Oral (capsules, powder). Fat-soluble — take with a meal containing fat. | Oral (tablets). Immediate-release (12.5 mg TID) or extended-release (25 mg QD). |
| Research Papers | 8 papers | 10 papers |
| Categories |
Mechanism of Action
Bacopa Monnieri
Bacopa's bacosides (bacosides A and B, bacopaside I-VII) enhance synaptic communication by increasing dendritic branching, spine density, and synaptic activity in the hippocampus via modulation of neural cell adhesion molecules (NCAM) and FGF-2. They modulate serotonin through 5-HT3 receptor antagonism (reducing anxiety) and 5-HT2A modulation, dopamine through D1/D2 receptor modulation, and acetylcholine through enhancement of choline acetyltransferase. Bacosides upregulate tryptophan hydroxylase (TPH) and serotonin transporter (SERT) expression, increasing serotonin synthesis and reuptake. The antioxidant properties of bacosides reduce lipid peroxidation and protein carbonylation in the hippocampus via free radical scavenging, protecting neurons from oxidative damage during memory formation. They may enhance CREB phosphorylation and BDNF expression.
Tianeptine
Tianeptine is a full agonist at mu-opioid (MOR) and delta-opioid (DOR) receptors, mediating both its antidepressant/anxiolytic effects and abuse potential at high doses. Paradoxically, it enhances serotonin reuptake via SERT—opposite to SSRIs—yet still produces antidepressant effects, possibly through opioid-mediated mood regulation. Tianeptine modulates glutamatergic signaling by reversing stress-induced downregulation of AMPA receptor subunits (GluA1/GluA2) and restoring synaptic plasticity. In the hippocampus and amygdala, it prevents stress-induced dendritic atrophy, spine loss, and CA3 pyramidal cell damage—likely through opioid receptor activation and downstream HPA axis effects. It increases BDNF levels and promotes neurogenesis. The combination of opioid agonism, glutamate normalization, and neuroplasticity enhancement underlies its unique profile.
Risks & Safety
Bacopa Monnieri
Common
Gastrointestinal discomfort (cramping, nausea, bloating), fatigue, dry mouth.
Serious
May interact with thyroid medications.
Rare
Increased bowel movements, decreased appetite.
Tianeptine
Common
Nausea, constipation, abdominal pain, headache, dizziness, dry mouth.
Serious
Opioid-like effects at high doses (euphoria, dependence, respiratory depression). Withdrawal syndrome with abrupt cessation after chronic high-dose use. Abuse and overdose deaths reported.
Rare
Hepatotoxicity, skin reactions.
Full Profiles
Bacopa Monnieri →
An Ayurvedic herb used for thousands of years as a memory enhancer. Modern research confirms it — Bacopa reliably improves memory formation, recall speed, and information retention. The catch is that benefits require 8-12 weeks of daily use to manifest; it is not an acute cognitive enhancer. The bacosides (active compounds) are also mildly sedating, making evening dosing common.
Tianeptine →
An atypical antidepressant with unique nootropic properties. Unlike SSRIs which increase serotonin, tianeptine is a mu-opioid receptor agonist and enhances serotonin reuptake. It reduces stress-induced neuronal damage in the hippocampus and amygdala, improving mood, cognition, and stress resilience simultaneously. Prescription medication in many countries but carries abuse potential at high doses.